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Purpose: Smoking is a serious public health problem worldwide. Some authors refer to it as the “silent epidemic of the
20th century.” It constitutes an important risk factor for ocular pathologies such as age-related macular degeneration
(ARMD), diabetic retinopathy, and neuropathy because the toxic effects of tobacco play a key role in the deterioration of
eye tissue. Damage to trabecular meshwork cells (TMC) and retinal ganglion cells (RGC), involving inflammation and
apoptosis mechanisms, has been proved in glaucoma. The aim of this study was to determine whether smoking influences
the progression of primary open angle glaucoma (POAG) in women.
Methods: This experimental study involved a sampling of consecutive cases of smokers, ex-smokers and non-smokers
women with POAG. One hundred and twenty women with POAG, aged 40–90 years, were enrolled (40 smokers, 40 ex-
smokers and 40 non-smokers). Samples of aqueous humor (AH) and plasma from each subject were obtained at the
beginning of the surgical procedures. Both inflammation and apoptosis processes in the subjects were studied by means
of enzyme immunoassay and western blot procedures respectively. We analyzed the interleukin-6 (IL-6) levels as an
inflammation marker and the expression of caspase-3 and poly (ADP-ribose) polymerase 1 (PARP-1) as apoptosis markers.
Results: IL-6, caspase-3, and PARP-1 levels were significantly higher in the smoker women who smoked than in the ex-
smoker and non-smoker glaucomatous groups of the same gender (p<0,05).
Conclusions: Inflammation and apoptosis marker levels increase with smoking in the aqueous humor and plasma samples
of POAG women. Smoking could be an important additional risk factor for glaucoma progression in elderly women.
Glaucoma  is  a  syndrome  characterized  by  high
intraocular pressure (IOP), an alteration of the optic nerve
head and a loss of visual field. When the loss of optic nerve
tissue is significant, patients suffer deterioration in vision.
Before this loss is quantifiable, patients may lose a significant
amount of optic nerve tissue, making the early diagnosis of
this  disease  critical  [1].  Glaucoma  is  the  major  cause  of
irreversible  blindness  worldwide.  There  are  66.8  million
people in the world who have glaucoma, with 6.7 million of
them  having  bilateral  blindness  [2,3].  Risk  factors  for
glaucoma include age, race, diabetes, myopia, hypertension,
cardiovascular diseases, and a family history of glaucoma
[4,5].
The genetic component of this disease is now undeniable.
Several  research  groups  have  studied  the  relationship  of
certain genes to glaucoma and certain mutations in some of
these genes have been associated with an increased risk of
developing  glaucomatous  disease  [6,7].  But  not  only  are
genetic  factors  key  to  the  development  and  evolution  of
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glaucomatous  optic  neuropathy,  but  so  are  environmental
factors.
Snuff usage, according to World Health Organization
data, is the leading cause of illness, disability, and premature
death in the world, which means that smoking is a serious
global public health concern. Of the approximately 1.3 billion
smokers in the world, some 6 million die annually because of
the  effects  of  using  tobacco  [8].  Nowadays,  smoking  is
considered a chronic addictive disease that causes problems
not only for the people who do it, but also for those who live
with them.
Smoking  is  associated  with  many  diseases,  including
allergies, hypertension, heart disease, and lung cancer [9,10].
It  is  also  related  to  eye  diseases,  mainly  with  optic
neuropathies and age-related macular degeneration [11,12].
Smoking causes high oxidative stress because tobacco smoke
contains oxidizing agents that produce free radicals [13]. A
free  radical  is  a  molecule  with  one  or  more  non-paired
electrons in its outer orbit, which makes it very unstable and
active. So the free radical will steal an electron from another
molecule and, in this way, create another free radical. This
produces a chain reaction which, if not stopped, will lead to
cell damage and even cell death by apoptosis [14].
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2953It is known that a significant loss of trabecular meshwork
cells (TMC) occurs in patients with glaucoma in an age-
related fashion [15]. Experimental studies in human [16] and
animal models [17] have shown that TMC and retinal ganglion
cells  (RGC)  die  by  apoptosis  in  glaucoma.  However,  the
switch-window in which cells start failing in their normal
functions and appear to undergo apoptotic cell death in both
the anterior and posterior eye segments in glaucoma remains
unknown. Understanding the molecular processes involved in
apoptosis regulation is a pivotal aspect for developing proper
anti-glaucoma therapies.
It has been recently discovered a caspase-independent
pathway of apoptosis that is driven by the nuclear enzyme poly
ADP ribose polymerase 1 (PARP-1) [18]. The PARP enzymes
constitute a family of cell signaling enzymes, also known as
the poly (ADP-ribose) synthetases and transferases, which
catalyze  the  poly  (ADP-ribosylation)  of  DNA-binding
proteins. Of the PARP family, PARP-1 was the first to be
characterized and up to now is the best known member. In
seriously  damaged  cells,  when  apoptosis  is  occurring,
PARP-1  is  the  target  of  caspase-3,  which  proteolizes  the
protein and divides it into two fragments. One (the 85 kDa
fragment)  contains  the  COOH-terminal  domain  (catalytic
domain), and the other (24 kDa) contains the NH2-terminal
domain (DNA union domain). This proteolysis mechanism
prevents DNA repair and allows the cell to initiate apoptosis
[19].  In  this  context,  overactivation  of  PARP-1  has  been
demonstrated  to  be  closely  related  to  the  pathogenic
mechanisms  of  various  diseases,  such  as  myocardial
infarction  [20],  diabetes  mellitus  [21],  neurodegenerative
disorders [22], and inflammatory processes [23]. It has been
shown  that  cigarette  smoke  can  induce  inflammatory
responses  [24-26],  and  researchers  have  been  detected
changes in the levels of several markers of inflammation (e.g.
IL-6 or IL-8), probably due to the effects of smoke [27-29].
Some cytokines have also been studied in relation to
glaucoma [30,31] (e.g., IL-6) because inflammatory processes
have been associated with this optic neuropathy. Not only has
IL-6 been associated with inflammatory responses, but it has
also been linked to apoptotic processes [32-35]. Tobacco has
also been associated with apoptotic processes because of the
toxic substances it contains [36,37], and it is known that TMC
and RGC die by apoptosis in glaucoma [38,39].
Taking all this into account, the aim of this study was to
analyze possible changes in the expression of pro-apoptotic
proteins (PARP1, caspase 3) and the levels of inflammatory
markers (IL-6) in aqueous humor and plasma of subjects with
POAG.
METHODS
The Doctor Peset University Hospital Review Boards and
Committees approved the protocols, which adhered to the
Helsinki guidelines for human research. An informed consent
agreement was signed by all study participants.
Subjects:  Patients  were  examined  by  experienced
ophthalmologists  in  the  corresponding  departments  of  the
study centers. A systematized ocular examination including
visual  acuity,  IOP,  biomicroscopy,  ocular  fundus
photographs, and visual field was performed on all suitable
patients.  According  to  the  inclusion/exclusion  criteria  (as
summarized  in  the  Table  1),  120  patients  diagnosed  with
POAG  and  scheduled  for  anterior  eye  segment  surgery
(Watson’s trabeculectomy technique) gave informed consent
to  participate  in  this  study  and  were  finally  enrolled  and
distributed into three groups: 1) smokers (S, n=40), 2) ex-
smokers (ES, n=40) and 3) non-smokers (NS, n=40).
Sampling  procedures:  Global  standards  for  subject
biosample workflow, transport, storage, and procedures were
strictly  followed.  Aqueous  humor  samples  were  obtained
from the eye at the onset of surgery by aspiration throughout
corneal  paracentesis,  using  a  27-gauge  needle  under  an
operating  microscope  (Zeiss).  Samples  were  collected  in
cryotubes. Once the aqueous humor was drawn, the cryotube
was labeled with patient data, and deposited into the freezer
at −20 °C for 1 h. Then, the cryotubes were immediately
transported to the laboratory to be frozen at −85 °C and to be
logged in until processing. Blood samples were extracted from
the antecubital vein at baseline. Then, plasma samples were
obtained by centrifugation at 1,000 rpm and −4 °C for 10 min,
collected in cryotubes and frozen at −85 °C.
Analytical procedures: The aqueous humor (AH) and
plasma samples were processed for biochemical and western
blot assays as follows.
Interleukin-6  level  determination—This  was
performed by the Interleukin-6 Human EIA kit from Cayman
Chemical (Cayman Chemical Co., Ann Arbor, MI), which is
TABLE 1. DEMOGRAPHIC CHARACTERISTICS OF PATIENTS.
 Features S mean (SD) ES mean (SD) NS mean (SD)
Age (years) 71.5 (7.0) 70.1 (11.3) 72.3 (7.2)
BCVA (Snellen) 0.79 (0.10) 0.83 (0.12) 0.82 (0.12)
IOP (mmHg) 25.1 (3.2) 25.7 (3.4) 23.7 (2.8)
S=Smoker; ES=Ex-Smoker; NS=Non-Smoker; SD=standard deviation; BCVA=Best Corrected Visual Acuity; IOP=Intraocular Pressure
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2954based on a double-antibody “sandwich” technique. An IL-6
molecule  is  binding  for  two  antibodies:  1)  monoclonal
antibody specific for IL-6 and 2) acetylcholinesterase:Fab’
conjugate. The enzymatic activity of acetylcholinesterase is
measured  at  412  nm.  The  concentration  of  the  IL-6  is
proportional to the amount of bound conjugate.
Total  protein  concentration  assays—This
determination  was  made  as  a  prelude  to  the  western  blot
technique, to load the same amount of protein for each sample.
The Bicinchoninic Acid Protein Assay Kit (Sigma-Aldrich,
Bellefonte,  PA)  was  used.  In  this  assay,  a  Cu2+-protein
complex is formed under alkaline conditions. Then, Cu2+ is
reduced to Cu1+. Finally, the bicinchoninic acid (BCA) forms
a purple-blue complex with Cu1+, and absorbance at 560 nm
was measured by means of a spectrophotometer.
Western blot—Samples were prepared by western blot
assays:
• Gel electrophoresis: 30 µg protein from each
sample was loaded on gel (NuPAGE 4%–12% Bis-
Tris Gel, Invitrogen, Philadelphia, PA). A molecular
weight  marker  was  also  loaded  (NuPAGE
Magicmark XP Western Standard, Invitrogen). The
electrophoresis was performed using a PowerEase
500 Power Supply (Invitrogen) at 150V for 90 min.
• Transfer to nitrocellulose membrane of 0.45 µm
pore  size  (Invitrogen)  was  performed  in  the
PowerEase 500 Power Supply at 30V for 60 min.
• Immunoblotting: A polyclonal antibody (PARP
H-250, Santa Cruz Biotechnology Inc., Santa Cruz,
CA) and Cleaved Caspase-3 (Asp175, Cell Signaling
Technology,  Danvers,  MA)  was  used  for
determining  PARP-1  and  caspase-3  expression.
Immunoblotting  was  performed  by  using  a
Invitrogen kit (WesternBreeze® Chromogenic Kit–
Anti-Rabbit).
Optical density of the respective bands was determined
using  the  Scion  Image  Analysis  System  (Scion  Corp.,
Frederick, MD). Data were analyzed with the SPSS program
(version 15.0 for Windows from SPSS Inc., Chicago, IL). We
used  the  one-way  ANOVA  to  compare  the  quantitative
variables between groups and the Student t test for comparing
two means. Significance level was set at a p-value of 0.05 or
less by a two-tailed test.
RESULTS
There were no significant differences in age, best corrected
visual acuity, or IOP between groups (Table 1). First, we
performed an ANOVA (ANOVA, Table 2). After that, we
performed a bivariate statistical analysis by means of the
Student t test (Table 3) to estimate differences between the
two means.
1. IL-6 levels were significantly different between
groups for the aqueous humor and plasma. In the
aqueous humor, IL-6 levels were significantly higher
in the smoker group than in the ex-smoker group and
also statistically higher in the ex-smoker group than
in the non-smoker group. In the plasma samples, the
IL-6 levels were statistically higher in the smoker
group compared to the other two groups. However,
the IL-6 levels were lower in the ex-smoker group
than in the non-smoker group, but the difference was
not statistically significant (Figure 1).
2. Data  from  the  cleaved  PARP-1  showed
significant differences between the study groups for
both  aqueous  humor  and  plasma.  The  levels  of
PARP-1  were  significantly  higher  in  the  smoker
group than in the ex-smoker group and also were
statistically higher in the ex-smoker group than in the
non-smoker group (Figure 2).
3. Caspase-3  levels  were  significantly  different
between our study groups for both aqueous humor
and plasma samples. The levels of caspase-3 were
TABLE 2. ANOVA RESULTS IN THE AQUEOUS HUMOR AND PLASMA SAMPLES.
Aqueous humor Plasma
Biomarkers Sum of
squares                              square





IL-6 (pg/ml) BG 2065173 2 1032586.657 392.370 1.308×10-10 333574.0 2 166787.006 47.965 6.125×10-16
  WG 307904.7 117 2631.664     406842.6 117 3477.288    
  Total 2373078 119       740416.7 119      
PARP-1 (rdu) BG 11084.596 2 5542.298 199.638 1.929×10-38 1053.545 2 526.772 20.209 2.892×10-8
  WG 3248.115 117 27.762     3049.755 117 26.066    
  Total 14332.712 119       4103.300 119      
CASP-3 (rdu) BG 1908.805 2 954.403 34.871 1.322×10-12 1722.728 2 861.364 25.013 9.035×10-10
  WG 3202.260 117 27.370     4029.061 117 34.436    
  Total 5111.065 119       5751.789 119      
IL-6=Interleukin-6; PARP-1=Poly(ADP-Ribose)Polymerase 1; CASP-3=Caspase 3; df=degrees of freedom; F=F statistic;
S=Significance; rdu=relative densitometric units; BG=Between Groups; WG=Within Groups
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2955statistically higher in smokers than in ex-smokers
and  non-smokers.  In  the  aqueous  humor,  the
caspase-3 levels were higher in the ex-smoker group
than  in  the  non-smoker  group.  However,  the
plasmatic caspase-3 levels were higher in the non-
smoker group than in the ex-smoker group. For both
aqueous  humor  and  plasma  samples,  differences
between the ex-smoker and non-smoker groups were
not significant (Figure 3).
DISCUSSION
It is known that primary open-angle glaucoma is a major cause
of  irreversible  blindness  worldwide.  Its  cause  remains
unknown,  so  the  study  of  the  risk  factors  for  this  optic
neuropathy is pivotal for managing the disease and avoiding
the  progression  to  blindness.  Thus,  we  have  studied  the
influence of smoking on the progression of this disease, taking
into consideration that the eye is naturally exposed to the
environment, which means that cigarette smoke can directly
affect it.
Although the study was conducted in a population of
women, there is no evidence that women have a higher risk of
Figure 1. Levels of interleukin-6 in aqueous humor and plasma of
the study groups.
Figure 2. Poly (ADP-ribose) polymerase 1 levels (85 kDa band),
measured  as  relative  densitometric  units  (rdu),  in  both  aqueous
humor and plasma samples of the study groups.
glaucoma than men. In any case, this neuropathy is a disease
associated with age, and it has been shown that some hormonal
factors influence POAG. Therefore, post-menopausal women
present an increased risk of progression of this disease. The
presence of more glaucomatous women than glaucomatous
men in the general population may be because the prevalence
of glaucomatous optic neuropathy increases with age and
women have a higher life expectancy than men.
Grzybowski  [40]  has  shown  that  smoking  produces
ischemia and oxidative stress and that smoking has a negative
impact on POAG surgery. Cheng et al. [41] also found a strong
association between smoking and glaucoma, suggesting that
the damage from smoke is probably due to the presence of
toxic substances that induce an increase in free radicals and a
decrease in antioxidants.
In the present work we have investigated the role of
smoking  in  the  expression  of  inflammation  (IL-6)  and
apoptosis (PARP-1, caspase-3) molecules in a gender-related
fashion. Our results agree with those of other researchers and
strongly  suggest  that  cigarette  smoking  increases  the
expression of pro-apoptotic molecules, markers of cell death.
Epidemiological  [42]  and  experimental  [43]  studies  have
shown  a  link  between  the  increased  caspase-3  levels  and
glaucoma  disease.  Likewise,  increased  levels  of  cleaved
PARP-1  [44]  and  increased  rates  of  apoptosis  have  been
previously described. In fact, these results are consistent with
the association between apoptosic cell death and glaucoma
found by other researchers [45,46].
Smoking is also associated with inflammation. Rodriguez
[47] conducted a study that found a strong connection between
the  increase  of  C-reactive  protein  and  smoking  and
established that this increase is directly related to the duration
of  smoking.  In  addition,  it  has  been  demonstrated  that
smoking increases oxidative stress [48] and that oxidative
stress plays a role in acute and chronic inflammation [49].
Because of this, we have evaluated herein the interleukin-6
levels in the aqueous humor and plasma, and our results show
that  smoking  influences  the  IL-6  levels  in  glaucomatous
Figure 3. Caspase-3 levels (relative densitometric units – rdu) in
aqueous humor and plasma samples of the study groups.
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2956females. Rummenie et al. [50], in a study about cigarette
smoke effects on tear and the ocular surface, observed that
IL-6 concentrations increased significantly in tear 24 h after
smoke exposure. Studying the progression of ARMD, Seddon
et al. [51] also found a relationship between IL-6 levels and
smoking.
Data presented in this work are consistent with the fact
that  habitual  smoking  increases  the  expression  of
inflammatory and apoptosis markers in glaucoma patients.
Since it is known that RGC die by apoptosis in glaucoma, we
theorized  that  the  increase  of  apoptotic  and  inflammation
markers in POAG due to smoking might contribute to the
progression of the disease.
In this work we studied the changes produced in the
expression  of  certain  molecules  by  tobacco  usage  in  a
population of women, and we observed how the expression of
the  molecules  studied  increased  with  smoking.  However,
there are some factors that we have not considered in our
study, such as passive smoking. Passive smoking is a universal
problem,  and  all  people  (smokers,  ex-smokers,  or
nonsmokers) may be exposed to tobacco smoke in public
places, at home, or at work. However, smokers do not usually
have a problem staying in smoky places, while nonsmokers
tend to avoid them.
We  are  currently  undertaking  a  project  to  attempt  to
evaluate whether smoking influences the expression of the
same molecules in men with glaucoma. Subsequently, if the
answer to this new study is positive, we will examine whether
the  influence  of  smoking  on  inflammatory  and  apoptotic
processes is greater in women or in men.
In summary, further research is needed in the context of
glaucoma biomarkers, the influence of exogenous risk factors
(such as smoking habits), IOP, and the morphological and
functional glaucoma test to recommend avoiding smoking,
particularly in older women.
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